Besqab and Stille report Q3 results: sales rise on housing demand and organic growth
Besqab's Q3 net sales jumped 61% on higher home sales, while Stille grew 23% but slightly missed revenue estimates. Source: Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Swedish residential developer Besqab reported Q3 net sales up 61% year on year, driven by higher home sales. Revenue came in at SEK 651.10 million, net income at SEK 86.40 million and gross profit at SEK 141.10 million. The company handed over the rental housing projects Femöringen and Inverness to buyers and plans several launches in the final quarter.
Swedish surgical instruments maker Stille posted Q3 net sales growth of 23% year on year, including 16.5% organic growth. Revenue was SEK 170.60 million against a consensus of SEK 175 million from two analysts. Adjusted EBITDA rose 29% to SEK 33.70 million, and gross margin widened to 49.9% from 48.8%.
The figures were reported by Reuters, based on LSEG data and company information.
why it matters
Both companies are small names on the Swedish market, so the results are unlikely to move the broader index. For investors tracking Sweden, they suggest that housing demand and margin gains in medical equipment are still holding up. Stille's revenue shortfall is a reminder that growth does not always match expectations.
tags
instruments
sources
- Sweden's Besqab Q3 net sales rise 61% on strong home sales — Reuters, 23 October 2026 at 05:15 UTC
- Sweden's Stille Q3 net sales rise year on year — Reuters, 23 October 2026 at 06:12 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗